Corient Private Wealth’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Corient Private Wealth's EXAS Position: Q1 2026 in Review
Corient Private Wealth sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 37,480 shares — an estimated $3.81M sold.
Corient Private Wealth first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $3.81M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Corient Private Wealth reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Corient Private Wealth sold 37,480 Exact Sciences shares in Q1 2026, an estimated $3.81M.
- Corient Private Wealth first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
- Corient Private Wealth's Exact Sciences position peaked at $3.81M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.